You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glycerol

Showing 1 - 25 of 638
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tympanosclerosis, Thickened Ears, Healthy Trial (Glycerol)

Not yet recruiting
  • Tympanosclerosis
  • +3 more
  • Glycerol
  • (no location specified)
Aug 10, 2022

Corticobasal Syndrome (CBS) Trial (RAVICTI 1.1 g/ml, Placebo)

Not yet recruiting
  • Corticobasal Syndrome (CBS)
  • RAVICTI 1.1 g/ml
  • Placebo
  • (no location specified)
Aug 1, 2023

Multi-Drug Resistant Organism Trial in Decatur (Allogeneic Microbiota in Glycerol (10%) (AMG))

Not yet recruiting
  • Multi-Drug Resistant Organism
  • Allogeneic Microbiota in Glycerol (10%) (AMG)
  • Decatur, Georgia
    Emory Long-Term Acute Care
Mar 20, 2023

Cystic Fibrosis Trial in Denver, Baltimore, Philadelphia (Ravicti low dose, Ravicti high dose, Placebo)

Terminated
  • Cystic Fibrosis
  • Ravicti low dose
  • +2 more
  • Denver, Colorado
  • +2 more
Mar 4, 2022

Performance Enhancing Product Use, Change, Body Weight, Change, Body Temperature Trial in La Ñora (PLACEBO, GLYCEROL)

Completed
  • Performance Enhancing Product Use
  • +5 more
  • PLACEBO
  • GLYCEROL
  • La Ñora, Murcia, Spain
    Research Center for High Performance Sport. Catholic University
Mar 15, 2022

ACHROMATOPSIA 7, Achromatopsia Trial in New York (PBA)

Not yet recruiting
  • ACHROMATOPSIA 7
  • Achromatopsia
  • New York, New York
    Edward S. Harkness Eye Institute
Apr 4, 2022

STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder Trial in Aurora, New York (Glycerol Phenylbutyrate 1100

Active, not recruiting
  • STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder
  • Glycerol Phenylbutyrate 1100 MG/ML [Ravicti]
  • Aurora, Colorado
  • +1 more
Jan 24, 2023

Monocarboxylate Transporter 8 Deficiency Trial in Rehovot (Glycerol Phenylbutyrate 1100 MG/ML)

Recruiting
  • Monocarboxylate Transporter 8 Deficiency
  • Glycerol Phenylbutyrate 1100 MG/ML
  • Rehovot, Israel
    Pediatric Endocrinology Unit, Kapan Medical Center
Aug 22, 2021

Parkinson's Disease Trial in Aurora (Glycerol Phenylbutyrate)

Completed
  • Parkinson's Disease
  • Glycerol Phenylbutyrate
  • Aurora, Colorado
    University of Colorado Denver Anschutz Medical Center
Apr 15, 2022

Low Anterior Resection Syndrome, Rectal Cancer Trial in Aarhus (Qufora Irrisedo Cone System, Glycerol "OBA")

Recruiting
  • Low Anterior Resection Syndrome
  • Rectal Cancer
  • Qufora Irrisedo Cone System
  • Glycerol "OBA"
  • Aarhus, Denmark
    Aarhus University Hospital, Department of Surgery
Jun 1, 2021

Hepatic Insufficiency, Hypoalbuminemia Trial in Dallas (Orally administered labeled glycerol)

Terminated
  • Hepatic Insufficiency
  • Hypoalbuminemia
  • Orally administered labeled glycerol
  • Dallas, Texas
    UT Southwestern Medical Center - Advanced Imaging Research Cente
Mar 15, 2022

Early Gastric Cancer, Rectal Polyp Trial in Worldwide (Endoscopic submucosal dissection, use of Orise Gel as lifting agent for

Not yet recruiting
  • Early Gastric Cancer
  • Rectal Polyp
  • Endoscopic submucosal dissection
  • +2 more
  • New York, New York
  • +3 more
Jul 22, 2021

Healthy Volunteers, Smoking Trial in Belfast (Reference cigarette, Cigarette with carob bean extract, Cigarette with cocoa

Completed
  • Healthy Volunteers
  • Smoking
  • Reference cigarette
  • +11 more
  • Belfast, Northern Ireland, United Kingdom
    Celerion
Dec 6, 2022

Ischemic Stroke, High Blood Pressure Trial in Sydney (Low-dose rtPA, Standard-dose rtPA, Intensive blood pressure (BP) lowering)

Completed
  • Ischemic Stroke
  • High Blood Pressure
  • Low-dose rtPA
  • +3 more
  • Sydney, New South Wales, Australia
    Royal Prince Alfred Hospital
Oct 5, 2021

Lung Injury Trial in Brussels (Nicotine free intake, Nicotine intake, Cessation intake)

Completed
  • Lung Injury
  • Nicotine free intake
  • +2 more
  • Brussels, Anderlecht, Belgium
    Erasme Hospital
Nov 2, 2020

Dermatitis, Atopic Trial in Sheffield (2% urea/20% glycerol cream, Miniderm® 20% cream, Diprobase® cream)

Completed
Has Results
  • Dermatitis, Atopic
  • 2% urea/20% glycerol cream
  • +2 more
  • Sheffield, United Kingdom
    The University of Sheffield Medical School
Dec 13, 2021

Type 1 Diabetes, Type 1 Diabetes With Hypoglycemia, Hypoglycemia Trial in Edinburgh (procedure, device, other)

Recruiting
  • Type 1 Diabetes
  • +5 more
  • Stepped hyperinsulinaemic-hypoglycaemic clamp study
  • +5 more
  • Edinburgh, United Kingdom
    Edinburgh Royal Infirmary/University of Edinburgh
Jan 13, 2022

Very Long-chain Acyl-CoA Dehydrogenase Deficiency, Trifunctional Protein Deficiency, Long-chain 3-hydroxyacyl-CoA Dehydrogenase

Completed
  • Very Long-chain Acyl-CoA Dehydrogenase Deficiency
  • +5 more
  • Portland, Oregon
    Oregon Health & Science University
Mar 5, 2021

Adrenoleukodystrophy Trial in Baltimore (glyceryl trierucate/glyceryl trioleate)

Terminated
Has Results
  • Adrenoleukodystrophy
  • glyceryl trierucate/glyceryl trioleate
  • Baltimore, Maryland
  • +1 more
Oct 22, 2020

Flap Necrosis Trial in Amiens (glucose measurement, lactacte measurement, pyruvate measurement)

Unknown status
  • Flap Necrosis
  • glucose measurement
  • +4 more
  • Amiens, France
    CHU Amiens
Jul 20, 2020

Dentin Hypersensitivity Trial in Riyadh (5% Sodium Fluoride Varnish, 15% Nanohydroxyapetite paste, Glycerol)

Completed
  • Dentin Hypersensitivity
  • 5% Sodium Fluoride Varnish
  • +2 more
  • Riyadh, ArRiyadh, Saudi Arabia
    Riyadh colleges of dentistry and pharmacy olaya campus
Mar 9, 2020

Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) Trial in Worldwide (UX007, Placebo)

Completed
Has Results
  • Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
  • Aurora, Colorado
  • +13 more
Jun 8, 2020

Obesity, Visceral Trial in Dallas ([U-13C3] glycerol, Empagliflozin, Placebo (for Empagliflozin))

Completed
Has Results
  • Obesity, Visceral
  • [U-13C3] glycerol
  • +2 more
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jan 22, 2020

Insulin Sensitivity Trial in San Antonio (Glucagon Infusion, Saline)

Recruiting
  • Insulin Sensitivity
  • Glucagon Infusion
  • Saline
  • San Antonio, Texas
  • +1 more
Sep 8, 2022

Type 2 Diabetes, Type 1 Diabetes Trial in San Antonio (Empagliflozin 25 MG, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • Type 1 Diabetes
  • Empagliflozin 25 MG
  • Placebo
  • San Antonio, Texas
    Texas Diabetes Institute/UH
Jul 31, 2023